Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317029,Aia19,Adjuvant induced arthritis QTL 19,2.98,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),10,69385595,112626471,Rat,n/a,region,qtl 1000,61325,Aia5,Adjuvant induced arthritis QTL 5,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,2317039,Aia6,Adjuvant induced arthritis QTL 6,4.31,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),10,69385595,112626471,Rat,n/a,region,qtl 1000,738023,Alc17,Alcohol consumption QTL 17,3.1,0.003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),6,1,35623029,Rat,n/a,region,qtl 1000,8693645,Alc31,Alcohol consumption QTL 31,3.7,0.038,drinking behavior trait (VT:0001422),calculated ethanol drink intake rate (CMO:0001615),6,135053,23600274,Rat,n/a,region,qtl 1000,12880396,Am13,Aortic mass QTL 13,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),10,93662786,112626471,Rat,n/a,region,qtl 1000,1578668,Bmd14,Bone mineral density QTL 14,3.8,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),6,6161722,76002731,Rat,n/a,region,qtl 1000,1578672,Bmd16,Bone mineral density QTL 16,6.2,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),10,100155035,110992275,Rat,n/a,region,qtl 1000,2300176,Bmd51,Bone mineral density QTL 51,11.7,0.0001,femur mineral mass (VT:0010011),bone mineral density (CMO:0001226),6,1,35623029,Rat,n/a,region,qtl 1000,2300190,Bmd52,Bone mineral density QTL 52,11.2,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),6,1,35623029,Rat,n/a,region,qtl 1000,2300172,Bmd57,Bone mineral density QTL 57,9.8,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),10,73008136,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),10,53621375,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,53621375,112626471,Rat,n/a,region,qtl 1000,724530,Bp149,Blood pressure QTL 149,,0.0001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,93886117,112626471,Rat,n/a,region,qtl 1000,1300137,Bp186,Blood pressure QTL 186,3.57,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),10,93886117,110992275,Rat,n/a,region,qtl 1000,1359023,Bp272,Blood pressure QTL 272,2.5,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,1120393,28706721,Rat,n/a,region,qtl 1000,1579915,Bp280,Blood pressure QTL 280,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,93662786,112626471,Rat,n/a,region,qtl 1000,1642980,Bp300,Blood pressure QTL 300,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,70800069,112626471,Rat,n/a,region,qtl 1000,2292436,Bp310,Blood pressure QTL 310,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,98079221,112626471,Rat,n/a,region,qtl 1000,2292438,Bp311,Blood pressure QTL 311,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,78970279,112626471,Rat,n/a,region,qtl 1000,2301972,Bp325,Blood pressure QTL 325,4.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),6,1,75623393,Rat,n/a,region,qtl 1000,10450493,Bp382,Blood pressure QTL 382,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,98079221,112626471,Rat,n/a,region,qtl 1000,10450498,Bp384,Blood pressure QTL 384,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,70166960,112626471,Rat,n/a,region,qtl 1000,61396,Bp9,Blood pressure QTL 9,4.8,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,71692298,112626471,Rat,n/a,region,qtl 1000,1578665,Bss16,Bone structure and strength QTL 16,4.4,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),6,6161722,76002731,Rat,n/a,region,qtl 1000,1578663,Bss18,Bone structure and strength QTL 18,3.6,,femur width (VT:1000666),femoral neck width (CMO:0001695),10,100155035,110992275,Rat,n/a,region,qtl 1000,2293709,Bss23,Bone structure and strength QTL 23,5.18,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),6,1,43665660,Rat,n/a,region,qtl 1000,2293646,Bss25,Bone structure and strength QTL 25,10.96,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293656,Bss28,Bone structure and strength QTL 28,6.79,0.0001,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),6,1,43665660,Rat,n/a,region,qtl 1000,2293650,Bss31,Bone structure and strength QTL 31,5.05,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),6,1,43665660,Rat,n/a,region,qtl 1000,2293663,Bss33,Bone structure and strength QTL 33,9.34,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293698,Bss43,Bone structure and strength QTL 43,5.33,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),10,62096293,107096293,Rat,n/a,region,qtl 1000,1549831,Bss6,Bone structure and strength QTL 6,4,,lumbar vertebra strength trait (VT:0010574),vertebra ultimate force (CMO:0001678),10,60450007,105450007,Rat,n/a,region,qtl 1000,2313105,Bss79,Bone structure and strength QTL 79,1.8,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),10,65992275,110992275,Rat,n/a,region,qtl 1000,2313103,Bss80,Bone structure and strength QTL 80,2,0.0001,tibia strength trait (VT:1000284),tibia midshaft endosteal cross-sectional area (CMO:0001716),10,65992275,110992275,Rat,n/a,region,qtl 1000,1354641,Bvd2,Brain ventricular dilatation QTL 2,6.36,0.001,brain ventricle morphology trait (VT:0000822),hydrocephalus severity score (CMO:0001881),10,96520816,110992275,Rat,n/a,region,qtl 1000,6893357,Bw102,Body weight QTL 102,0.5,0.36,body mass (VT:0001259),body weight (CMO:0000012),10,83389828,104994768,Rat,n/a,region,qtl 1000,6893366,Bw106,Body weight QTL 106,0.3,0.47,body mass (VT:0001259),body weight (CMO:0000012),10,73467158,112626471,Rat,n/a,region,qtl 1000,7387312,Bw125,Body weight QTL 125,3,0.0047,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight (CMO:0000356),10,67880046,112626471,Rat,n/a,region,qtl 1000,7411542,Bw127,Body weight QTL 127,5.5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,1,42388212,Rat,n/a,region,qtl 1000,1558652,Bw57,Body weight QTL 57,4.2,0.0008,body mass (VT:0001259),body weight (CMO:0000012),10,94170766,112626471,Rat,n/a,region,qtl 1000,2303589,Bw87,Body weight QTL 87,2,,body mass (VT:0001259),body weight (CMO:0000012),10,85079943,112626471,Rat,n/a,region,qtl 1000,70171,Cari1,Carrageenan-induced inflammation QTL 1,4.9,0.0005,hypodermis integrity trait (VT:0010550),inflammatory exudate volume (CMO:0001429),10,55678976,112626471,Rat,n/a,region,qtl 1000,631267,Cia20,Collagen induced arthritis QTL 20,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14827894,107857673,Rat,n/a,region,qtl 1000,631269,Cia22,Collagen induced arthritis QTL 22,8.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,631270,Cia23,Collagen induced arthritis QTL 23,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,1302404,Cia27,Collagen induced arthritis QTL 27,2.6,0.0045,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),10,79927661,112626471,Rat,n/a,region,qtl 1000,1576307,Cia28,Collagen induced arthritis QTL 28,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,99492217,107857673,Rat,n/a,region,qtl 1000,61436,Cia5,Collagen induced arthritis QTL 5,4.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,94486204,107857673,Rat,n/a,region,qtl 1000,61449,Ciaa2,CIA Autoantibody QTL 2,7.1,,blood autoantibody amount (VT:0003725),calculated serum anti-type 2 collagen antibody titer (CMO:0001279),10,65590122,110590122,Rat,n/a,region,qtl 1000,12880384,Cm107,Cardiac mass QTL 107,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),,93662786,112626471,Rat,n/a,region,qtl 1000,12880385,Cm108,Cardiac mass QTL 108,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),,93662786,112626471,Rat,n/a,region,qtl 1000,12880395,Cm109,Cardiac mass QTL 109,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),10,93662786,112626471,Rat,n/a,region,qtl 1000,1331791,Cm31,Cardiac mass QTL 31,3.84606,,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,23861015,112626471,Rat,n/a,region,qtl 1000,1598843,Cm63,Cardiac mass QTL 63,2.6,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),6,1,23620518,Rat,n/a,region,qtl 1000,1354616,Despr12,Despair related QTL 12,,0.0012,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),6,1,35623029,Rat,n/a,region,qtl 1000,1581559,Eae18,Experimental allergic encephalomyelitis QTL 18,,0.00002,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),10,67988218,110992091,Rat,n/a,region,qtl 1000,2292589,Emca10,Estrogen-induced mammary cancer QTL 10,,0.048,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),6,1120393,46120393,Rat,n/a,region,qtl 1000,1576309,Emca7,Estrogen-induced mammary cancer QTL 7,4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),6,2537030,111715717,Rat,n/a,region,qtl 1000,7411603,Foco13,Food consumption QTL 13,5.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,42388212,Rat,n/a,region,qtl 1000,7411584,Foco4,Food consumption QTL 4,4.3,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,44015370,Rat,n/a,region,qtl 1000,2317754,Glom25,Glomerulus QTL 25,3.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,86566908,112626471,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14827894,110992275,Rat,n/a,region,qtl 1000,2312672,Insul15,Insulin level QTL 15,,0.01,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),10,60875260,105875260,Rat,n/a,region,qtl 1000,9589129,Insul24,Insulin level QTL 24,19.06,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),6,1,42388212,Rat,n/a,region,qtl 1000,12880398,Kidm67,Kidney mass QTL 67,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),10,93662786,112626471,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9841807,108540162,Rat,n/a,region,qtl 1000,1600367,Mcs15,Mammary carcinoma susceptibility QTL 15,4.5,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,88544136,107545372,Rat,n/a,region,qtl 1000,70193,Mcs7,Mammary carcinoma susceptibility QTL 7,2.38,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,75544754,112626471,Rat,n/a,region,qtl 1000,2298548,Neuinf7,Neuroinflammation QTL 7,3.4,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),10,75544754,112626471,Rat,n/a,region,qtl 1000,634320,Niddm49,Non-insulin dependent diabetes mellitus QTL 49,4.41,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),10,91689348,112626471,Rat,n/a,region,qtl 1000,61363,Oia3,Oil induced arthritis QTL 3,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90296897,112626471,Rat,n/a,region,qtl 1000,631538,Oia5,Oil induced arthritis QTL 5,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90041957,112626471,Rat,n/a,region,qtl 1000,631539,Oia6,Oil induced arthritis QTL 6,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,100460820,108540162,Rat,n/a,region,qtl 1000,4889492,Pancm2,Pancreatic morphology QTL 2,3.2,,pancreatic beta cell morphology trait (VT:0005217),ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814),10,80239190,112626471,Rat,n/a,region,qtl 1000,61354,Pia10,Pristane induced arthritis QTL 10,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,1576313,Pia25,Pristane induced arthritis QTL 25,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,99492217,107857673,Rat,n/a,region,qtl 1000,8552962,Pigfal16,Plasma insulin-like growth factor 1 level QTL 16,9.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),6,1,42388212,Rat,n/a,region,qtl 1000,738024,Sach5,Saccharine consumption QTL 5,3.9,0.00039,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),6,1,44570292,Rat,n/a,region,qtl 1000,9589048,Scfw3,Subcutaneous fat weight QTL 3,4.57,0.001,subcutaneous adipose mass (VT:1000472),abdominal subcutaneous fat pad weight (CMO:0002069),6,1,42388212,Rat,n/a,region,qtl 1000,1576308,Schws1,Schwannoma susceptibility QTL 1,,0.0041,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),10,41260363,106105607,Rat,n/a,region,qtl 1000,2312668,Scl65,Serum cholesterol level QTL 65,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),10,60875260,105875260,Rat,n/a,region,qtl 1000,1354664,Slep2,Serum leptin concentration QTL 2,4.49,,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),6,1120393,75023446,Rat,n/a,region,qtl 1000,2312662,Slep8,Serum leptin concentration QTL 8,,0.05,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),10,60875260,105875260,Rat,n/a,region,qtl 1000,1549905,Stresp10,Stress response QTL 10,6.83,0.0066,stress-related behavior trait (VT:0010451),number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960),6,1,35623029,Rat,n/a,region,qtl 1000,1298078,Stresp5,Stress response QTL 5,2.99,0.00025,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,43289657,108540162,Rat,n/a,region,qtl 1000,1578758,Tcas9,Tongue tumor susceptibility QTL 9,3.29,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),6,1,25048718,Rat,n/a,region,qtl 1000,1331743,Uae28,Urinary albumin excretion QTL 28,4.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),6,1,41917988,Rat,n/a,region,qtl